21245100|functional|C0205245^C0542341^C2700217|start=0|end=10|CONC
21245100|activation|C1879547|start=11|end=21|ACTI
21245100|estrogen receptor|C1414461^C3811131|start=29|end=46|PROC^GENE
21245100|alpha|C0439095^C2003941^C2350010|start=47|end=52|CONC
21245100|aromatase|C1366496|start=57|end=66|GENE
21245100|hdac|C3539637^C1422386|start=74|end=78|GENE
21245100|inhibitor|C1999216|start=79|end=88|CONC
21245100|negative|C2825415^C0205160^C2825491|start=114|end=122|CONC
21245100|tumors|C0027651|start=123|end=129|DISO
21245100|approximately|C0332232|start=144|end=157|CONC
21245100|breast cancers|C0006142|start=165|end=179|DISO
21245100|estrogen receptor|C1414461^C3811131|start=199|end=216|PROC^GENE
21245100|alpha|C0439095^C2003941^C2350010|start=217|end=222|CONC
21245100|respond to|C1553423|start=257|end=267|CONC
21245100|endocrine therapy|C0279025|start=268|end=285|PROC
21245100|tumors|C0027651|start=296|end=302|DISO
21245100|repression|C0035143|start=312|end=322|PHYS
21245100|due to|C0678226|start=332|end=338|CONC
21245100|epigenetic|C1655731|start=339|end=349|OCCU
21245100|methylation|C0025723^C1159269|start=372|end=383|PHYS
21245100|histone deacetylation|C1156201|start=388|end=409|PHYS
21245100|reason|C0392360|start=420|end=426|CONC
21245100|investigated|C1292732|start=431|end=443|CONC
21245100|ability|C0085732|start=448|end=455|PHYS
21245100|histone deacetylase inhibitor|C2266853|start=463|end=492|PHYS
21245100|ent|C0150934^C1274038^C1304535^C1417861|start=505|end=508|OCCU^GENE^ANAT^CONC
21245100|trigger|C1444748^C0032930|start=513|end=520|PHYS^CONC
21245100|aromatase|C1366496|start=549|end=558|GENE
21245100|breast cancer|C0006142^C0678222|start=562|end=575|DISO
21245100|cells|C3282337^C0007634|start=576|end=581|ANAT
21245100|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=609|end=618|PROC^CONC
21245100|sensitivity|C2349185^C1522640^C1511883^C2346484^C0036667^C0312418|start=633|end=644|PHEN^PHYS^CONC
21245100|aromatase inhibitor|C2757060|start=652|end=671|PHYS
21245100|ent|C0150934^C1274038^C1304535^C1417861|start=688|end=691|OCCU^GENE^ANAT^CONC
21245100|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=692|end=701|PROC^CONC
21245100|tumor cells|C0431085|start=705|end=716|ANAT
21245100|increased|C0442805^C0205217|start=717|end=726|CONC
21245100|expression|C0185117^C0017262^C2911684|start=727|end=737|PROC^PHYS^CONC
21245100|aromatase|C1366496|start=753|end=762|GENE
21245100|enzymatic activity|C2267219|start=779|end=797|PHYS
21245100|aromatase|C1366496|start=801|end=810|GENE
21245100|dose|C0869039^C0178602|start=817|end=821|CONC
21245100|dependent|C3244310^C1701901^C0851827|start=822|end=831|CONC
21245100|in vitro|C1533691^C2827718^C0021135|start=844|end=852|CONC
21245100|in vivo|C1515655|start=857|end=864|CONC
21245100|aromatase|C1366496|start=887|end=896|GENE
21245100|upregulation|C0041904|start=897|end=909|PHYS
21245100|sensitization|C1325847^C3839736|start=922|end=935|DISO^PHYS
21245100|breast cancer|C0006142^C0678222|start=939|end=952|DISO
21245100|cells|C3282337^C0007634|start=953|end=958|ANAT
21245100|tumor growth|C0598934|start=986|end=998|DISO
21245100|rate|C1521828^C0871208^C1549480|start=999|end=1003|ACTI^CONC
21245100|lower|C1548802^C0441994^C2003888|start=1022|end=1027|ACTI^ANAT^CONC
21245100|tumor|C0027651^C1578706|start=1031|end=1036|DISO^CONC
21245100|xenografts|C0520484|start=1037|end=1047|PROC
21245100|following|C0332282|start=1048|end=1057|CONC
21245100|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=1058|end=1067|PROC^CONC
21245100|ent|C0150934^C1274038^C1304535^C1417861|start=1073|end=1076|OCCU^GENE^ANAT^CONC
21245100|combination|C1947911^C0205195|start=1090|end=1101|OBJC^CONC
21245100|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1125|end=1132|OBJC^CONC
21245100|tumors|C0027651|start=1133|end=1139|DISO
21245100|ent|C0150934^C1274038^C1304535^C1417861|start=1153|end=1156|OCCU^GENE^ANAT^CONC
21245100|plus|C0332287|start=1157|end=1161|CONC
21245100|lung|C0819757^C0024109^C1278908|start=1187|end=1191|ANAT
21245100|growth|C2911660^C0220844^C0018270^C1621966|start=1209|end=1215|PHYS^ACTI
21245100|tumor cells|C0431085|start=1219|end=1230|ANAT
21245100|significant|C0750502^C1546944^C0237881|start=1239|end=1250|CONC
21245100|reduction|C0301630^C0392756^C0441610|start=1251|end=1260|PROC^PHEN^CONC
21245100|visible|C0205379|start=1280|end=1287|CONC
21245100|microscopic|C0205288|start=1292|end=1303|CONC
21245100|foci|C0205234|start=1304|end=1308|CONC
21245100|show|C1547282|start=1322|end=1326|CONC
21245100|ent|C0150934^C1274038^C1304535^C1417861|start=1332|end=1335|OCCU^GENE^ANAT^CONC
21245100|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=1336|end=1345|PROC^CONC
21245100|negative|C2825415^C0205160^C2825491|start=1404|end=1412|CONC
21245100|tumors|C0027651|start=1413|end=1419|DISO
21245100|provide|C1999230^C0359589|start=1442|end=1449|OBJC^ACTI
21245100|strong|C0442821|start=1452|end=1458|CONC
21245100|rationale|C0392360^C2699007|start=1459|end=1468|CONC
21245100|immediate|C1548167^C1697779^C0205548^C3272601^C0205253|start=1473|end=1482|CONC
21245100|clinical evaluation|C1261322^C1516634|start=1483|end=1502|PROC
21245100|combinations|C0453882|start=1506|end=1518|OBJC
21245100|aromatase inhibitors|C2757060|start=1546|end=1566|PHYS
21245100|treat|C1292734^C1522326^C0087111|start=1570|end=1575|PROC^CONC
21245100|negative|C2825415^C0205160^C2825491|start=1579|end=1587|CONC
21245100|endocrine|C0521425^C0553665^C0014136|start=1592|end=1601|DISO^CONC^ANAT
21245100|resistant|C0332325^C2827757|start=1602|end=1611|PHEN^CONC
21245100|breast cancers|C0006142|start=1612|end=1626|DISO
